CLINICAL_TRIALS
trial_result
· 2007-05-09
Clinical Trial Update: A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes [Phase 3]
Summary
This document notes the completion of a Phase 3 trial comparing vildagliptin to placebo in patients with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED